Multiple Myeloma Flashcards

1
Q

what is multiple myeloma?

A

cancer of the PLASMA cells in the bone marrow.

plasma cells are a type of B lymphocytes which produce antibodies. you get large quantities of a single type of antibodies being produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

multiple myeloma

A

myeloma affects multiple areas of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MGUS- Monoclonal gammopathy of undetermined significance

A

excess of a single type of antibody or antibody components without features of myeloma or cancer

incidental finding
significance is unclear
follow up for monitor of progression of the disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

smouldering myeloma

A

progression of MGUS with higher levels of antibodies or antibody components.

premalignant and more likely to progress to myeloma than MGUS

Waldenstrom’s macroglobulinaemia is a type of smouldering myeloma where there is excessive IgM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the pathophysiology of myeloma?

A

plasma cells (b cells) (b lymphocytes) are activated to produce a certain antibody. if there is a genetic mutation, then a specific type of plasma cell rapidly and uncontrollably multiplies

plasma cells produce ONE type of antibody (immunoglobulins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

immunoglobulins

A
aka antibodies
complex molecule
two heavy chains
two light chains 
Y shaped

help the immune system to recognise and fight infection

5 main types A, G, M, D, E

in myeloma, one of these will be in abundance. most is IgG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bence Jones protein

A

this can be found in urine of many patients with myeloma. actually a part (subunit) of the antibody called the light chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

myeloma bone disease

A

as a result of increased osteoclast activity and supressed osteoblast activity you can develop myeloma bone disease

osteoclast= absorb bone (break it down, C=cut)

osteoblast= deposit bone (build bone, B) (osteoid and minerals) (ca2+, Po4-)
RANKL binds to RANK on osteoclast which stimulates osteoclastic activity.
osteoblast also release OPG which decreases osteoclastic activity.

metabolism is therefore imbalanced as more is being broken than formed.

this is all due to cytokines released from plasma cells and stromal cells when they are in contact with plasmaa cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

where does myeloma bone disease happen?

A

the skull, spine, long bones and ribs.

abnormal bone metabolism is patchy -some areas are very thin and some are normal.
‘osteolytic lesions’

weak points can lead to pathological features (vertebral fracture)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

hypercalcaemia in myeloma bone disease

A

hypercalcaemia (high ca2+) as a result of calcium being reabsorbed from the bone into the blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

plasmacytomas

A

people with myeloma can develop plasmacytomas. these are individual tumours made up of cancerous plasma cells. can occur in bones and replace normal tisssue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

anaemia in myeloma

A

cancerous plasma cells invade bone marrow (infiltration) which causes a suppression of other blood cells e..g RBC - anaemia, low neutrophils- neutropenia, low platelets- thrombocytopenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

myeloma of renal disease

A

Patients with myeloma often develop renal impairment. This is due to a number of factors:

High levels of immunoglobulins (antibodies) can block the flow through the tubules
Hypercalcaemia impairs renal function
Dehydration
Medications used to treat the conditions such as bisphosphonates can be harmful to the kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

hyper viscocity in myeloma

A

normal plasma viscosity / internal friction of the flow of blood is between 1.3-1.7 times that of water. (blood is quicker than water)

if there is more protein then there is more plasma viscosity.

this can cause:
Easy bruising
Easy bleeding
Reduced or loss of sight due to vascular disease in the eye
Purple discolouration to the extremities (purplish palmar erythema)
Heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

main clinical features of myeloma

A

(CRAB)

C – Calcium (elevated)
R – Renal failure
A – Anaemia (normocytic, normochromic) from replacement of bone marrow.
B – Bone lesions/pain

  • infections
  • fractures, dehydration
risk factors: Older age
Male
Black African ethnicity
Family history
Obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

investigations for myeloma

A

anyone over 60 with persistent bone pain, back pain, unexplained fractures.

FBC (low white blood cell count in myeloma)
hypercalcaemia, anaemia, paraprotein
reduction of normal anitbiodies
Calcium (raised in myeloma)
ESR (raised in myeloma)
Plasma viscosity (raised in myeloma)
serum protein electrophoresis
urine Bence-Jones protein test
BLIP 
B --- Bence–Jones protein (request urine electrophoresis)
L – Serum‑free Light‑chain assay
I – Serum Immunoglobulins
P – Serum Protein electrophoresis

bone marrow biopsy
imaging: MRI, CT, skeletal survey (xray images of full skeleton)

17
Q

Xray signs of myeloma

A

Punched out lesions
Lytic lesions
“Raindrop skull” caused by many punched out (lytic) lesions throughout the skull that give the appearance of raindrops splashing on a surface

18
Q

management of myeloma

A

control disease
relapsing-remitting disease
MDT

chemotherapy:
bortezomid
thalidomide
dexamethasone

stem cell transplant
VTE prophylaxis (LMWH)
19
Q

management of myeloma bone disease

A

bisphosphonate
radiotherapy
orthopaedic surgery
cement augmentation into vertebral fractures or lesions

20
Q

myeloma complications

A
Infection
Pain
Renal failure
Anaemia
Hypercalcaemia
Peripheral neuropathy
Spinal cord compression
Hyperviscosity
21
Q

multiple myeloma pathophysiology osteoclastic activity promotion

A

secrets IL3 by increasing osteoclastic activity.

secrete DKK1 which inhibits OPG by osteoblast (Again most osteoclast activity)

stimulates osteoclast through RANK ligan

light chains are small enough to be filtered by the kidneys- renal failure. urined out- bence-jones protein